Zobrazeno 1 - 10
of 22
pro vyhledávání: '"D Blanquez Martinez"'
Autor:
M Hayon Ponce, X Diaz Villamarin, Ás Raquel, CL Dávila Fajardo, P Nieto Gómez, D Blanquez Martinez, I Casas Hidalgo
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Purpose The aim of this study was to evaluate the real-world efficacy and safety of adding Liraglutide in inadequately controlled patients with oral antidiabetic drugs. Material and methods This observational study assessed the efficacy an
Autor:
Ás Raquel, C García Fernández, CL Dávila Fajardo, P Nieto Gómez, M Hayon Ponce, D Blanquez Martinez, X Diaz Villamarin
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Low vitamin D levels have been postulated to be associated with insulin resistance, suggesting that vitamin D plays a role in glucose metabolism and homeostasis. Purpose To determine the prevalence of suboptimal vitamin D status in obese p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A Caballero Romero, A Rodriguez Delgado, R Álvarez Sánchez, CL Dávila Fajardo, P Moreno Raya, P Nieto Gómez, D Blanquez Martinez, M Hayon Ponce, X Diaz Villamarin
Publikováno v:
Eur J Hosp Pharm
Background Cross-sex hormone therapy (CHT) is known to lead to alterations in the cardiovascular risk factor (CVRF). Purpose To assess changes in lipid profile and other CVRF in transsexual participants receiving CHT. Material and methods Retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834e4663d16820d050853fea2e8367eb
https://europepmc.org/articles/PMC7535396/
https://europepmc.org/articles/PMC7535396/
Publikováno v:
Drug information and pharmacotherapy.
Background Non-valvular atrial fibrillation (NVAF) is the most common cardiac arrhythmia in clinical practice, affecting nearly 1% of the general population.1 In Spain, the stipulated recommendations to select anticoagulant are: use of novel oral ant
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R Morón Romero, LJ Martinez, CL Dávila Fajardo, X Diaz Villamarin, M Valle Corpas, D Blanquez Martinez, MJ Soto Pino, J Cabeza Barrera, E Raya Alvarez, Mdc Gonzalez Medina
Publikováno v:
European Journal of Hospital Pharmacy. 23:A142.1-A142
Background Tocilizumab (TCZ) is a humanised monoclonal antibody inhibitor of interleukin 6 receptor, indicated in combination with methotrexate in the treatment of rheumatoid arthritis (RA) in patients with inadequate response or intolerance to prior
Autor:
R Morón Romero, A Caballero Romero, A Rodriguez Delgado, G Rodriguez Torne, J Cabeza Barrera, C Lara Ramos, M Valle Corpas, MC González Medina, I Casas Hidalgo, D Blanquez Martinez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A136.2-A136
Background Extravasation of cytostatic agents is one of the major complications in cancer treatment with anthracyclines. There is a lot of information about the management of extravasations with ‘classical’ anthracyclines but liposomal anthracycl
Autor:
A Caballero Romero, C Gómez Peña, R Morón Romero, C García Fernández, Mdc Gonzalez Medina, M Valle Corpas, S Ruiz Fuentes, D Blanquez Martinez, I Casas Hidalgo
Publikováno v:
European Journal of Hospital Pharmacy. 22:A15.1-A15
Background Hormone treatment based on analogues of gonadotropin releasing hormone (GnRH) with antiandrogens is the first-line treatment for prostate cancer. This treatment produces a PSA reduction, improvement of symptoms and tumour regression. When
Autor:
I Casas Hidalgo, MC González Medina, C Gómez Peña, M Valle Corpas, J Cabeza Barrera, A Caballero Romero, C García Fernández, D Blanquez Martinez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A66.1-A66
Background Strongyloides stercoralis is one of the most common parasites in tropical areas. Nowadays, the treatment of such parasite is based on ivermectin. However, ivermectin is not marketed in Spain. Hospital pharmacists are responsible for permit